NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (NRXP)

CUSIP: 629444209

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
+510,346
Put/Call ratio
1%
SEC-reported price per share
$2.44
Indexed holders
18
Value change
+$1,261,065
Number of buys
18
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,443,612

Security key

629444209

Report period

Q2 2024

Indexed institutions

18

Top holders

10

Ownership snapshot

Top reported holders of NRXP - NRX Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Daniel C. Javitt
Disclosed value leader
Daniel C. Javitt
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5 13F Highest disclosed value: $3,082,170 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Daniel C. Javitt has the largest disclosed position value at $3.08M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Daniel C. Javitt's linked filing trail.
Disclosed position value Top 5
Daniel C. Javitt $3.08M
BRAC Lending Group LLC $188.9K
Big Rock Partners Sponsor, LLC $166.1K
VANGUARD GROUP INC $679.6K
AdvisorShares Investments LLC $290.1K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Daniel C. Javitt
3/4/5
10%+ Owner
—
denominator unverified
$3,082,170
9,634,793 shares
— 29 Nov 2022
BRAC Lending Group LLC
3/4/5
10%+ Owner
—
denominator unverified
$188,880
590,435 shares
— 24 May 2021
Big Rock Partners Sponsor, LLC
3/4/5
10%+ Owner
—
mixed-class rows
$166,129
619,315 shares
mixed-class rows
— 24 May 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$679,557
1,440,045 shares
— 31 Mar 2024
AdvisorShares Investments LLC
13F
Company
13F
—
denominator unverified
$290,121
614,793 shares
— 31 Mar 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$198,240
419,954 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
18
Shares
510,346
Indexed holders
18
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2024 vs Q2 2026 Across Filers

Q2 2026 indexed holders
47
Q2 2024 indexed holders
18
Indexed holder difference
-29
Investor Q2 2026 Shares Q2 2024 Shares Share Diff Share Chg % Q2 2026 value Q2 2024 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .